LEADER 01315nam  2200361Ia 450 
001 9910698808203321
005 20090604141551.0
035   $a(CKB)5470000002397788
035   $a(OCoLC)370423088
035   $a(EXLCZ)995470000002397788
100   $a20090604d2005      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $ehow to comply with the Pediatric Research Equity Act
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research,$d[2005]
215   $a18 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on June 4, 2009).
300   $a"Draft guidance".
300   $a"Procedural".
300   $a"September 2005".
517   $aGuidance for industry 
606   $aPediatrics$xResearch$xGovernment policy$zUnited States
615  0$aPediatrics$xResearch$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698808203321
996   $aGuidance for industry$93434577
997   $aUNINA